Containing Airborne Transmission of COVID-19 and Its Implications for Global Economic Recovery

Abstract

COVID-19 was first reported in December 2019 in Wuhan, China; however, it took international health experts another six months to establish the airborne nature of transmission of the disease. The transmission of the infection through aerosolized virus particles opens a new frontier in global pandemic control initiatives. It necessitates the need for appropriate economic policies to end the COVID-19 recession in most parts of the world. Mass vaccination and herd immunity are potent tools in combatting the challenge of COVID-19. Global vaccination against the disease is also gaining momentum. However, new variants and infection surges threaten to undermine critical gains. Furthermore, complete vaccination of the world population may be many years away. Therefore, it is essential to design public policies and business strategies in a world of great uncertainty. Understanding the airborne transmission of coronavirus will help business leaders craft meaningful operational procedures to protect their stakeholders and minimize costly business disruptions. It will also help the policymakers to avoid economically costly lockdowns. International success in indoor air purification, outdoor air pollution mitigation, widespread adoption of hand hygiene, and universal mask usage can significantly help pandemic control and increase the efficacy of various pandemic control measures. Controlling the pandemic may help countries in opening their economies and kickstarting global travel in the post-COVID-19 world. Such actions may also help in lessening the global burden of many other respiratory diseases. They may, in turn, save countless lives while dramatically reducing premature deaths. Such health gains may be conducive towards boosting GDP, decreasing healthcare costs, increasing productivity, and improving health equities. Controlling the COVID-19 pandemic remains the prime directive of all global public policy measures. Investments in aerosolized virus particle transmission mitigation offer a unique opportunity to achieve health improvement goals whose positive impacts may remain potent for generations to come.